- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 237/14 - Oxygen atoms
Patent holdings for IPC class C07D 237/14
Total number of patents in this class: 399
10-year publication summary
|
31
|
25
|
24
|
41
|
27
|
32
|
31
|
16
|
25
|
11
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| FMC Corporation | 813 |
18 |
| Sumitomo Chemical Company, Limited | 8969 |
11 |
| Hoffmann-La Roche Inc. | 3825 |
9 |
| Syngenta Participations AG | 1492 |
9 |
| Takeda Pharmaceutical Company Limited | 2699 |
9 |
| Merck Patent GmbH | 5739 |
8 |
| Bayer AG | 3562 |
8 |
| Bristol-myers Squibb Company | 4764 |
7 |
| F. Hoffmann-La Roche AG | 7800 |
7 |
| Lantheus Medical Imaging, Inc. | 165 |
7 |
| Novartis AG | 10175 |
6 |
| Abbvie Inc. | 1799 |
6 |
| Celgene Quanticel Research, Inc. | 154 |
6 |
| Ottawa Hospital Research Institute | 113 |
6 |
| Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 876 |
6 |
| University of Ottawa | 241 |
6 |
| Theravance Biopharma R&D IP, LLC | 360 |
6 |
| Calico Life Sciences LLC | 118 |
6 |
| Syngenta Crop Protection AG | 6738 |
5 |
| Centre National de La Recherche Scientifique | 11077 |
5 |
| Other owners | 248 |